Effects of lead on the kidney: roles of high-affinity lead-binding proteins. by Fowler, B A & DuVal, G
Environmental Health Perspectives
Vol. 91, pp 77-80, 1991
Effects of Lead on the Kidney: Roles of
High-Affinity Lead-Binding Proteins
by Bruce A. Fowler* and George DuValt
Lead-induced nephropathy produces both tubular and interstitial manifestations of cell injury, but
the pathophysiology ofthese leisons isnot completely understood. Delineation ofthe molecular fac-
torsunderlying renalhandling oflead is one ofcentral importance inunderstanding the mechanisms
of renal cell injury from this agent. Recent studies from this laboratory have identified several dis-
tincthigh-affinity lead-bindingproteins(PbBP) fromratkidneyandbrainthatappeartoplay critical
roles inthe intracellular bioavailability oflead to several essential cellular processes inthese target
tissues atlow dose levels. The PbBPfromratkidney hasbeenshowntobe aspecific cleavageproduct
of a2-microglobulin, which is a member of the retinol-binding protein superfamily. Recent prelimi-
nary Western blot and immunohistochemical studies have shown that a polyclonal antibody to the
renal PbBP does not recognize the brain PbBP, which appears to be achemically similar, but distinct
molecule. These studies have also shown that the renal PbBP is selectively localized in only certain
nephronsandonlyspecific segmentsoftherenalproximaltubule. Thestrikingnephror.andcell-type
specificity ofthe localization reaction could result from physiological differences in nephron func-
tional activity or selective molecular uptake mechanisms/metabolism differences that act to define
target cell populations in the kidney. In addition, other preliminary studies have shown that short-
term, high-dose lead exposure produces increased excretion ofthis protein into the urine with con-
comitant decreases in renal concentrations.
Introduction
The kidney is a major target organ system for lead
(1,2) with documented effects on a number ofessential
physiological and biochemical functions. In addition,
there also appearstobe variation betweenindividuals,
and in rats (3), differences between sexes with regard
to susceptibility to lead nephropathy. There is hence a
pressing need to delineate the factors that predispose
individuals to the nephrotoxic effects of lead and the
relationships ofthosefactorstothe mechanisms oflead
action.
Studies from this laboratory (4-10) have identified
several high-affinity lead-binding proteins (PbBP)
from rat kidney and brain that appear to act as recep-
tors for lead and mediate its activity within these tar-
gettissues(11). Thepresentreport is anupdate ofthese
studies with regard to purification ofthese molecules,
their immunohistochemical localization within the
kidney, and responsiveness to short-term, high-dose
lead exposure. Such data are clearly essential to un-
derstanding the role(s) of these molecules in deter-
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miningtargetcell/tissue susceptibility to lead andthe
potential use ofthese molecules as kidney-specific bio-
logical indicators of lead nephropathy early in the
toxic process.
Materials and Methods
Purification of Renal PbBP Purification of the
renal PbBP was carried out as previously described
(10,12), using a combination of Sephadex G-75 and
DEAE anion-exchange column chromatography fol-
lowed by reverse-phase, high-performance liquid chro-
matography using both nondenaturing columns.
Preparation ofPolyclonal Antibodies. Prepara-
tion of rabbit anti-rat polyclonal antibodies was con-
ductedby injectingrabbitswithpurifiedrenalPbBPin
Freunds adjuvant according to established methods
(G. E. DuVal, manuscript submitted).
Immunohistochemidal Localization of PbBP
within the Kidney. Immunohistochemical localiza-
tion of PbBP was accomplished by exposing paraffin-
embedded sections of control rat kidney to the poly-
clonal antibody followed by reaction with goat anti-
rabbit antibody conjugated with peroxidase. The sec-
tions were then incubated with diaminobenzidine
(DAB) for varying time periods to develop color (13).
Dot Blot Assays ofKidney and Urine. To assess
the effects ofprolonged, high-dose oral exposure ofrats
to lead in drinking water, a dot-blot assay using theFOWLER AND DUVAL
methods ofDominet al. (14)wasemployed. Kidneyand
urine samples of untreated control rats and rats ex-
posed to lead acetate in drinking water at concentra-
tions of 0, 1, or 3% for 1 to 7 weeks were blotted onto
nitrocellulose paper,reactedwiththerabbitpolyclonal
antibody described above, followed by reaction with an
"251-labeled goat anti-rabbit antibody. Densitometric
scanswereusedtoquantifythereaction, andthe assay
was calibrated using purified renal PbBP standards.
Results
Purification studies ofthe renal PbBP coupled with
N-terminal analyses demonstrated that the renal
PbBP exists as two forms in the kidney, which are dif-
ferentiated only by the cleavage of the first 9-N ter-
minal residues from higher molecular weight form.
InsertionoftheN-terminal sequences into acomputer-
ized protein sequence data base showed a 100% se-
quence homology with the rat protein a2-microglobu-
lin. This protein, which is a member of the retinol-
binding protein superfamily (15), is produced most
extensively in the livers of male rats and to a much
lesser extent in female rats of breeding age. The pro-
teinhasbeen showntobeunderpositive androgen con-
trol (15). Western blot analyses using our polyclonal
antibody demonstrated that the cleaved form is the
major entity present in the kidney and that it is this
cleavedformthatiscomplexedwithnuclearchromatin
asjudged by KCl extracts ofcontrol rat kidney nuclei
(unpublished observations). These data confirm and
extend previous in vitro (8-9) nuclear translocation
studies with isolated nuclei. Immunohistochemical
studies (Fig. 1) showed that the ae2-microglobulin was
primarily localized in lysosomes the descending sec-
ond segment (S2) of only selected proximal tubules.
Some faint staining also appeared to be present in the
cytoplasm ofthese cells and some third (S3) segments
(Fig. 1). The importance ofthese data is that they con-
FIGURE 1. Immunohistochemical localization of ca2-microglobulin
(PbBP) in S2 segments of specific nephrons of rat kidney. Note
that the peroxidase staining is observed in both the lysosomes
and cytoplasm ofthe cells.
firm and extend previous reports by others(15,16) that
indicatedthatthe second segment isthe chieflocaliza-
tion site for a2-microglobulin in the kidney. The knowl-
edge that two forms of the protein are present in the
kidney and that only certain nephrons appear to con-
tainreactive materialhas notbeenpreviouslyreported.
Further,preliminarystudiesusingthedot-blotassay
for a2-microglobulin in kidney and urine (Fig. 2) showed
an apparent dose-related increase in the excretion of
thisproteinintothe urine andconcomitantdecrease in
renalconcentrations ofratsexposedtoleadindrinking
water at 1 or 3% for 7 weeks. The onset ofthe increase
occurred after 2 weeks of exposure but appeared to
vary in magnitude between weeks, perhaps as a func-
tion oftoxicity, water intake, or urine volume/osmolal-
ity. Furtherstudiesareneededtoevaluatethesemodu-
lating factors. The significance ofthe data rests with
the apparent rapidity with which this response occurs
and that these increases in PbBP excretion probably
occur prior to the onset ofchronic renal damage. The
association of the response with the renal-specific
cleaved form ofa2-microglobulin is also important be-
cause it confers a renal specificity to this protein as a
biological indicator ofrenal tubular dysfunction. The
sensitivity of the radioimmunological methods used
forthisdemonstration are alsoofgreatpotential value
in providing an early end point for chemical-induced
cell injury.
Low-dose and chronic lead exposure studies are in
progress to determine the threshold of this response
under these conditions. In addition, other studies are
in progress to purify hypothesized analogous PbBP
from nonhuman primate and human tissues. Given
the ubiquitous nature of the retinol-binding protein
family inmammalsand similarities inrenalresponses
to lead, it is considered likely that chemically similar
proteinswillbe identified andpurified, whichwill per-
mit the development of radioimmunoassays such as
those demonstrated in the present report for human
populations.
Discussion
Results ofthe above studies are consistent with the
hypothesis (11) that the renal PbBP now identified as
a cleaved form ofa2-microglobulin acts as a target tis-
sue-specific receptor for lead and mediates the action
of this ubiquitous toxicant in mammals. A diagram-
matic representation of the current hypothesis is
shown in Figure 3. Under this hypothesis, lead enter-
ing into renal proximal tubule cells is complexed with
a2-microglobulin, which is highly resistant to com-
plete degradation (15). The elevated presence of the
cleaved form of a2-microglobulin in the kidney nuclei
suggeststhat itisthisformthat iscapable ofsurviving
proteolysis and entering the nucleus with subsequent
binding to regulatory-promoting regions of DNA.
These events lead to the observed (17,18) novel alter-
ations in renal gene expression associated with lead
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FIGURE 2. Results of dot-blot assay for :x2-microglobulin (PbBP) in
kidney and urine ofrats exposed to 0, 1, or 3% lead in drinking
water for 7 weeks showing dose-related increase in urine and
concomitant decrease in renal content.
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FIGURE 3. Diagram of current hypothesis for cs2-microglobulin
(PbBP) as a lead receptor in renal proximal tubule cells showing
apical uptake, cleavage of 9 N-terminalresidues, uptake intothe
cell nucleus, and attendant changes in renal gene expression.
uptake intothe nucleus. It isfurtherhypothesized that
some of these novel gene products may be oncogenes
whose expression may account for the carcinogenic ef-
fects oflead in rodents and persons with high expres-
sion levels ofthe analogous human proteins.
The apparent increase in excretion ofa2-microglobu-
lin in rats following short-term, high-dose oral expo-
sure to lead in drinking water indicates that the rat
kidney is highly responsive to elevated lead exposure
prior to the onset ofa general nephropathy. A similar
response in humans with increased urinary excretion
ofan analogous protein could hence also permit early
detection of lead-induced nephropathy at an early
stage ofdevelopment. Further studies are currently in
progress to evaluate this possibility in nonhuman pri-
matesandhumansexposedtoleadoverprolongedtime
periods.
Finally, we hypothesize that giventhe propensity for
a2-microglobulin to aggregate in the presence of lead
into higher molecular weight species (12), this protein
and its hypothesized analogs in other species also play
a major role in the formation ofthe pathognomic lead
intranuclear inclusionbodies(19,20)withinkidney tu-
bule cell nuclei. Further studies are needed to fully
evaluate this idea.
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